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Background: This study explored the association between single nucleotide polymorphisms (SNPs) in the CD40
gene, rs4810485 G > T and rs1883832 C > T, as well as disease susceptibility and severity in knee osteoarthritis (KOA)
in the Chinese Han population.
Method: Peripheral venous blood was collected from 133 KOA patients (KOA group) and 143 healthy people
(control group) from December 2012 to November 2013. The patients in the KOA group were classified into mild,
moderate and severe groups according to disease severity. Polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP) was used to test the genotypes of all subjects. Binary logistic regression analyses were
performed to analyze the risk factors for KOA.
Results: The KOA group was significantly different from the control group in living environment (P < 0.05). The KOA
group had a lower frequency of TT genotype and T allele distribution of rs4810485 G > T compared with the control
group, and rs4810485 G > T TT genotype and T allele may associate with low incidence of KOA (all P < 0.05). Besides, T
allele and mutant homozygous TT genotype of rs1883832 C > T increased the susceptibility to KOA. Genotype and allele
distribution of rs4810485 G > T and rs1883832 C > T were significantly different among the mild, moderate and severe
groups (P < 0.05). There were more patients with rs4810485 G > T GG genotype and rs1883832 C > T TT genotype in the
severe group than other genotypes of these two SNPs. According to binary logistic regression analysis, rs4810485 G > T
TT genotype could alleviate disease severity in KOA, rs1883832 C > T TT genotype increase the severity of KOA and living
environment is an important external factor that affects KOA severity.
Conclusions: These data provide evidences that rs4810485 G > T and rs1883832 C > T in the CD40 gene may
be associated with disease susceptibility and severity in KOA.
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Knee osteoarthritis (KOA) is a degenerative disease with
joint pain, stiffness, and function degeneration with a
more prevalent incidence among middle- and old-aged
groups [1, 2]. The clinical treatment for KOA patients
usually combines drug therapy and non-drug therapy,
among which the latter mainly includes exercise and
acupuncture, and common KOA drugs include non-
steroidal anti-inflammatory drugs, intra-articular
glucocorticoid and intra-articular hyaluronic acid [3].
Although KOA is affected by many factors, the damage
of meniscus occurred in the process of reconstruction
surgery is a major cause of KOA [4]. According to statis-
tics, patients with both anterior cruciate ligament (ACL)
injury and meniscus injury have an incidence rate of
KOA as high as 70% within 15 to 20 years after injury
[5]. It is found that similar to osteoporosis and fracture;
reduced cartilage thickness may also be one of the
factors that predispose to KOA [6]. Due to the suscepti-
bility and high incidence of KOA, it is of great import-
ance to find early diagnosis markers of KOA to improve
KOA treatment effect [2].
Cluster of Differentiation 40 (CD40) is a type I trans-
membrane glycoprotein composed of 277 amino acids
with a molecular weight of 40 ~ 50 kDa [7]. Human
CD40 gene is located at chromosome 20q11-13, contain-
ing eight introns and nine exons [8, 9]. Through inter-
action with its ligand CD40L, CD40 plays an important
role in cellular and humoral immunity, and it can acti-
vate inflammatory response in the human body and pro-
mote the progression of atherosclerosis [10, 11]. CD40
rs1883832 C > T includes CC, CT, and TT genotypes
with their promoters located at Kozak region, in which
the occurring gene mutation greatly impacts the gene
translation efficiency [12]. At present, a number of stud-
ies have found that single nucleotide polymorphisms
(SNPs) at CD40 gene promoter -1 is associated with
numerous immuno-inflammatory diseases, such as
Graves’ disease as well as acute coronary syndrome
(ACS) [13, 14]. Although previously classified as a non-
inflammatory arthritis, osteoarthritis (OA) has now been
generally recognized as a inflammatory disease [15].
CD40 rs1883832 was found associated with biopsy-
proven giant cell arteritis (GCA) [16]. Moreover, the as-
sociation of rs4810485 G > T with systemic lupus erythe-
matosus (SLE) has been investigated by many
researchers but without consistent results [17, 18]. Vaz-
giourakis found that rs4810485 G > T minor allele T is
under-represented in SLE patients and correlates with
reduced CD40 expression [19]. Nevertheless, the litera-
ture investigating association between CD40 rs4810485
G > T and rs1883832 C > T and KOA was limited in
numbers. This paper intends to explore the relationship
between SNPs in the CD40 gene (rs4810485 G > T andrs1883832 C > T), disease susceptibility and severity in
KOA, so as to find an effective target for early diagnosis
and treatment of KOA.
Methods
Ethics statement
This study was approved by the Ethics Committee of
Xiangya Hospital, Central South University and in ac-
cordance with the standards of the National Research
Council. Informed consent was obtained from each
patient prior to our study.
Study subjects
A total of 133 patients diagnosed with KOA in Xiangya
Hospital, Central South University from December 2012
to November 2013 were recruited as KOA group, (n =
133) comprised of 39 males and 94 females with a mean
age of 58.24 ± 9.66 years. KOA diagnosis was in accord-
ance with the KOA criteria laid down by Association of
Rheumatology Health Professionals (ARHP) [20]. Exclu-
sion criteria are as follows: joint diseases caused by other
reasons, such as inflammatory arthritis, traumatic arth-
ritis, suppurative arthritis, chronic inflammation, infec-
tious diseases and tumor or skeletal dysplasia; patients
with no less than 3 metacarpophalangeal joint involve-
ments that are in grade 2–4 of Kellgren-Lawrence (KL)
grading. Another 143 healthy individuals were included
into the control group, containing 52 males and 91 fe-
males with a mean age of 59 (58.2 ± 6.7) years. Members
in the control group underwent clinical examination,
and X-ray confirmed that they did not have KOA or
other arthritis. They also had no symptoms and signs of
related joint diseases such as pain, swelling, tenderness
and limited activity, or family history of KOA. All sub-
jects had complete clinical data, including age, sex, body
mass index (BMI), smoking and drinking status, heavy
physical labor and living environment [21]. Smoking
status was be divided into three categories: (1) never
smoking; (2) used to smoke; (3) still smoking. People
who are addicted to smoking were excluded from this
study as subjects. In China, the light, medium and heavy
drinking scales can be defined as 1.3 ~ 20 g, 20 ~ 50 g
and > 50 g of daily alcohol intake. All patients in this
study were light or occasional drinkers, indicating daily
alcohol intake not exceeding 20 g and 2 ~ 3 times a
week. For an 8 h work-day, if the average 8-h energy
consumption is no less than 7310.2 J/person and work-
ing time ≥ 73%, namely, if the working time is more than
350 min, it can be defined as heavy labor. Living envir-
onment is closely related to human life, where light in-
tensity and air humidity are two objective factors
affecting living environment, according to which the re-
search subjects can be divided into two types: (1) bright
+ dry type; (2) damp + dark type.
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In accordance with the severity grading of KOA clinical
comprehensive index [22], six indicators (pain, swelling,
walking difficulty, joint friction sound (sense), limitation
of activity and X-ray change) were used to assess the
KOA severity. According to the accumulative score of
each indicator, mild means 6 points, moderate 7 to 11
points, and severe 12 to 18 points. In the KOA group,
the mild group is comprised of 49 cases, moderate group
44 cases, and severe group 40 cases. Patients in the mild
group exhibited no obvious symptoms; instead they usu-
ally felt joint stiffness, knee coldness or discomfort
which could be slightly improved after activity. In the
moderate group, patiens showed acute knee inflamma-
tion after violent activity, which was relieved by rest or
symptomatic treatment. Knee ache and discomfort oc-
curred when sitting up and symptoms were relieved after
walking for a while. Patients in the severe group had un-
bearable knee pain, and had difficulty of going upstairs
and downstairs, as well as squatting or standing. A long
walk would cause swelling in the knee joint with some
mucus. Moving their knees would cause a sound along
with limitation of activity, joint deformity and even po-
tential crippling.
Polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP)
Based on the genomic data of Chinese Han population
in HapMap, this study was conducted as follows: litera-
ture review was done before searching for Tag-SNP and
FAST SNP [23] to find the functional mutation sites of
CD40 gene. At last, rs4810485 G > T and rs1883832 C >
T were identified as the polymorphic loci that were
detected in this study (Additional file 1: Figure S1). On
the day of admission, 2 mL of peripheral venous blood
was extracted from the subjects before 9 AM. Blood
samples were anti-coagulated with ethylenediaminetetra-
acetic acid (EDTA). DNA was extracted using phenol-
chloroform extraction method; the concentration was
determined and then preserved at -70 °C. DNA frag-
ments of rs4810485 G > T and rs1883832 C > T were
amplified with their DNA as the template respectively.
Primer was designed with the bio-software Primer Prem-
ier 5.0 (Premier, Pala Alto, CA, USA). The upstream
primer sequence of rs4810485 G > T was 5’-ATCCCC-
CAAGTACCTGGCTCCT-3’ and the downstream was
5’-CCTTGCTGCTTCCCTTGCTTTC-3’. The upstream
primer sequence of rs1883832 C > T was 5’-CCTCTT
CCCCGAAGTCTTCC-3’ and the downstream was 5’-
GAAACTCCTGCGCGGTGAAT-3’. The volume of
PCR amplification reaction was 20 μL, containing 2.0 μL
of 10 × PCR buffer, 2.0 μL of 0.3 mmol/L dNTPs, 1.0 μL
of upstream (10 μM) and downstream primers (10 μM)
respectively, 1.0 μL of template DNA (2.5 ng/μL), 1.0 Uof TaqDNA polymerase. The lack of 20 μL volume could
be supplemented by ddH2O. Reaction conditions for
rs4810485 G > T were a total of 42 cycles of denatur-
ation for 30 s at 94 °C, annealing for 35 s at 56 °C, ex-
tending for 45 s at 72 °C, and extending for 10 min at
72 °C as the end of reaction with 320 bp product. PCR
amplification product of 10 μL was dealt with by 5 U re-
striction endonuclease SfaNI in water for 5 h at 37 °C.
Reaction conditions for rs1883832 C > T were pre-
denatured for 5 min at 94 °C, then a total of 35 cycles of
denaturation for 30 s at 94 °C, annealing for 45 s at 61 °
C, extending for 45 s at 72 °C, and at last extending for
10 min at 72 °C. PCR amplification product of 10 μL
was cleaved at rs1883832 C > T by 5 U restriction endo-
nuclease NcoI, and reaction lasted for 6 h at 37 °C.
Shrimp alkaline phosphatase (Promega Corporation,
Madison, WI, USA) and exonuclease I (Epicentre) were
used to purify PCR product, then SNaPshot Multiplex
kit (ABI Company, Oyster Bay, NY, USA) was used for
extending reaction, and Promega was used to purify the
product of extension. The samples were loaded in
ABl3130XL and SNP typing was conducted through
GeneMapper4.0 (ABI Company, Oyster Bay, NY, USA).
Statistical analysis
The statistical analyses were conducted with SPSS21.0,
and measurement data were presented by mean ± stand-
ard deviation (SD). Data consistent with normal distribu-
tion was analyzed using t-test and variance analysis, and
data not conforming to normal distribution was analyzed
using rank-sum test. Enumeration data were presented
by number or ratio, differences between groups were an-
alyzed using Chi-Square Test; multiple sets of data were
analyzed using partition of chi-square test, and rank
sum test was used to compare genotypes of different
severities. Binary logistic regression analysis was used to
analyze the risk factors related to disease severity of
KOA. Disease severity of KOA was taken as the
dependent variable, and rs4810485 G > T, rs1883832 C >
T, age, gender, BMI, smoking status, alcohol consump-
tion, heavy labor and living environment were taken as
the independent variable. Odds ratios (OR), 95% confi-
dential interval (CI), and P-value were calculated. P <
0.05 was considered statistically significant.
Results
Comparisons of baseline characteristics between the KOA
group and the control group
There was no significant difference in age, gender, BMI,
smoking status, alcohol consumption, and heavy labor
between the KOA group and the control group (all P >
0.05). The percentage of patients who had lived in a
damp and dark environment was much higher in the
KOA group than in the control group (89.47% vs.
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factor affecting KOA (Table 1).
The DNA sequencing analysis of CD40 gene
Agarose gel electrophoresis of PCR-amplified products
showed that rs4810485 G > T was a 320 bp single band
before enzyme cleavage. And after enzyme cleavage, G/
G homozygote was a 320 bp band (GG genotype); G/T
heterozygote included 136 bp, 183 bp, and 320 bp bands
(GT genotype); T/T homozygote included 136 bp and
183 bp bands (TT genotype) (Fig. 1a). The results of
DNA sequencing were consistent with those tested by
PCR-RFLP. PCR-amplified products at rs1883832 C > T
were 302 bp. According to the restriction enzyme NcoI
fragments, there were three genotypes (Fig. 1b): two
bands for CC genotype (169 bp, 133 bp), three bands for
CT genotype (302 bp, 169 bp, and 133 bp), and one band
for TT genotype (302 bp). Confirmed by DNA sequen-
cing, they were consistent with the results of enzyme
digestion.
Comparisons of genotype frequency distributions and
allele frequencies of CD40 rs4810485 G > T and rs1883832
C > T between the KOA and control groups
Genotype distributions and allele frequencies of
rs4810485 G > T and rs1883832 C > T in the KOA group
and the control group are shown in Table 2. Genotype
distributions of all polymorphisms were found to conform
to Hardy-Weinberg equilibrium (P > 0.05), indicating thatTable 1 Comparisons of baseline characteristics between the
KOA group and the control group
Baseline characteristic KOA group Control group P
(n = 133) (n = 143)




BMI (kg/m2) 23.60 ± 3.07 22.95 ± 2.82 0.068
Smoking status (%)
Never 100 (75.19) 102 (71.33) 0.577
Ever 8 (6.02) 7 (4.90)
Still 25 (18.8) 34 (23.78)
Alcohol consumption (%)
Yes 48 (36.09) 48 (33.57) 0.660
No 85 (63.91) 95 (66.43)
Heavy labor (%) 37 (27.82) 39 (27.27) 0.919
Living environment <0.001
Good (Bright + dry) 14 (10.53) 133 (93.01)
Poor (Dark + damp) 119 (89.47) 10 (6.99)
Note: KOA Knee osteoarthritis, BMI Body mass indexthe population was well represented. The KOA group was
significantly different from the control group in genotype
distribution and allele frequency of rs4810485 G > T (P <
0.05). Compared with patients carrying GG genotype, pa-
tients with TT genotype had significantly lower risk of
KOA (GG vs TT: OR = 0.194, 95%CI = 0.097 ~ 0.387, P <
0.001). The susceptibility to KOA in individuals carrying
T allele significantly decreased compared with those carry-
ing G allele (G vs T: OR = 0.410, 95%CI = 0.290 ~ 0.577, P
< 0.001), indicating that homozygous TT genotype and T
allele may be protective factors for KOA. Besides, patients
with rs1883832 C > T TT genotype had increased suscep-
tibility to KOA compared with CC genotype (CC vs TT:
OR = 2.914, 95%CI = 1.413 ~ 6.010, P = 0.003), which sug-
gests that rs1883832 C > T T allele and mutant homozy-
gous TT genotype increased the susceptibility to KOA.
Correlation analysis between SNPs in CD40 gene and
clinical characteristics of KOA patients
The correlation of rs4810485 G > T and rs1883832 C > T
with KOA patients’ age, gender, BMI, smoking status, al-
cohol consumption, and heavy labor is shown in Table 3.
No significant difference was found between different
genotypes of rs4810485 G > T and rs1883832 C > T with
age, gender, BMI, smoking status, alcohol consumption
and heavy labor (all P > 0.05).
The relationship between CD40 gene polymorphism and
KOA severity
The correlation analysis between different genotypes and
KOA severity is shown in Table 4. There were significant
differences in genotype and allele distributions of
rs4810485 G > T and rs1883832 C > T among the mild,
moderate and severe groups (all P < 0.05). There were
more patients with rs4810485 G > T GG genotype and
rs1883832 C > T TT genotype in the severe group than
other genotypes of these two SNPs.
Binary logistic regression analysis for disease severity of
KOA
Binary logistic regression analysis was performed and
the results showed that rs4810485 G > T and rs1883832
C > T were both related to KOA. TT genotype of
rs4810485 G > T could alleviate disease severity of KOA
while TT genotype of rs1883832 C > T increases the se-
verity of KOA (both P < 0.05). Age, gender, BMI, smok-
ing status, alcohol consumption and heavy labor had
little impact on the severity of KOA, while living envir-
onment is considered an important external factor that
affects KOA severity (all P < 0.05) (Table 5).
Discussion
Osteoarthritis is the world’s most common inflammatory
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Fig. 1 Electrophoresis map of CD40 rs4810485 G > T and rs1883832 C > T. Note: a, CD40 rs4810485 G > T polymorphism: 1 and 5, GG genotype; 2
and 4, TT genotype; 3 and 6, GT genotype; b, CD40 rs1883832 C > T polymorphism: 1 and 5, TT genotype; 2 and 6, CT genotype; 3 and 4, CC
genotype; CD40, Cluster of Differentiation 40
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the life quality of patients [25]. KOA is a main cause of
constant knee pain. According to statistics, majority of
people suffer from frequent knee pain, which leads to
the limitation of joint function and activity [26]. In re-
cent years, with people’s deepening awareness about the
impact of genetic factors on the KOA onset, the role of
gene polymorphism in the occurrence and development
of KOA has attracted widespread attention [27]. This
paper intends to explore the correlation of gene poly-
morphism of CD40 rs4810485 G > T and rs1883832 C >
T with disease susceptibility and severity in KOA.
First, this study found that, patients who had lived in
damp and dark environments had a higher risk of suffer-
ing from KOA, suggesting that living environment is an
external factor, which was related with the severity of
KOA. A previous study has confirmed damp livingTable 2 Comparisons of genotype distributions and allele frequenci
KOA and control groups
SNP KOA group Control group
rs4810485 G > T
GG 44 (33.08%) 21 (14.69%)
GT 63 (47.37%) 58 (40.56%)
TT 26 (19.55%) 64 (44.76%)
GT + TT 89 (66.92%) 122 (85.31%)
G allele 151 (57.14%) 100 (34.97%)
T allele 115 (42.86%) 186 (65.03%)
rs1883832 C > T
CC 21 (15.79%) 43 (30.07%)
CT 75 (56.39%) 74 (51.75%)
TT 37 (27.82%) 26 (18.18%)
CT + TT 96 (72.18%) 117 (81.82%)
C allele 117 (43.98%) 160 (55.94%)
T allele 149 (56.02%) 126 (44.06%)
Note: CD40 Cluster of Differentiation 40, KOA Knee osteoarthritis, OR Odds ratio, CI Cenvironment as one of the risk factors for KOA [28].
Therefore, improvement of ventilation and lighting of a
living environment can also effectively alleviate suscepti-
bility to KOA [29].
The study found that homozygous TT genotype and T
allele of rs4810485 G > T may be protective factors in
the pathogenesis of KOA, while T allele and homozygote
TT genotype of rs1883832 C > T increased the suscepti-
bility to KOA. Besides, there were more patients with
rs4810485 G > T GG genotype and rs1883832 C > T TT
genotype in the severe group than other genotypes of
these two SNPs. Our binary logistic regression analysis
verified that rs4810485 G > T TT genotype decreased
disease severity of KOA, while rs1883832 C > T TT
genotype increased disease severity of KOA. At present,
CD40 rs4810485 is one of the most studied gene poly-
morphisms that is closely related to the susceptibility toes of CD40 rs4810485 G > T and rs1883832 C > T between the
χ2 P OR (95%CI)
Ref.
4.226 0.040 0.518 (0.276 ~ 0.974)
22.95 < 0.001 0.194 (0.097 ~ 0.387)
12.95 < 0.001 0.348 (0.194 ~ 0.627)
Ref.
26.42 < 0.001 0.410 (0.290 ~ 0.577)
Ref.
5.553 0.019 2.075 (1.124 ~ 3.830)
8.595 0.003 2.914 (1.413 ~ 6.010)
0.082 1.680 (0.934 ~ 3.024)
Refer
7.884 0.005 1.617 (1.155 ~ 2.264)
redibility interval, SNP Single nucleotide polymorphism
Table 3 Correlations of CD40 rs4810485 G > T and rs1883832 C > T polymorphisms with clinical characteristics of KOA patients
Clinical characteristic rs4810485 G > T P rs1883832 C > T P
GG (44) GT (63) TT (26) CC (37) CT (75) TT (21)
Age 0.858 0.883
< 61 years 25 (56.82) 39 (61.90) 16 (61.54) 13 (61.90) 46 (61.33) 21 (56.76)
≥ 61 years 19 (43.18) 24 (38.10) 10 (38.46) 8 (38.10) 29 (38.67) 16 (43.24)
Gender 0.230 0.300
Male 16 (36.36) 14 (22.22) 9 (34.62) 8 (38.10) 18 (24.00) 13 (35.14)
Female 28 (63.64) 49 (77.78) 17 (65.38) 13 (61.90) 57 (76.00) 24 (64.86)
BMI (kg/m2) 0.107 0.086
19≤ Y ≤ 26 33 (75) 52 (82.54) 16 (61.54) 12 (57.14) 59 (78.67) 30 (81.08) 33 (75)
Y < 19 or Y > 26 11 (25) 11 (17.46) 10 (38.46) 9 (42.86) 16 (21.33) 7 (18.92) 11 (25)
Smoking status (%) 0.699 0.289
Yes 10 (22.7) 11 (17.46) 4 (15.38) 4 (19.05) 11 (14.67) 10 (27.03)
No 34 (77.3) 52 (82.54) 22 (84.62) 17 (80.95) 64 (85.33) 27 (72.97)
Alcohol consumption (%) 0.911 0.943
Yes 17 (38.61) 22 (34.92) 9 (34.62) 7 (33.33) 27 (36.00) 14 (37.84)
No 27 (61.36) 41 (65.08) 17 (65.38) 14 (66.67) 48 (64.00) 23 (62.16)
Heavy labor 10 (22.73) 19 (30.16) 8 (30.77) 0.653 7 (33.33) 18 (24.00) 12 (32.43) 0.534
Note: CD40 Cluster of Differentiation 40, KOA Knee osteoarthritis, BMI Body mass index
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tosus (SLE) [30, 31]. CD40, rs1883832 polymorphism
can produce high expression of CD40 by up-regulating
the transcription or translation efficiency of CD40 gene,
and the abnormal expression of CD40 will lead to the
increase of pro-inflammatory cytokine and cause dis-
eases [16, 32]. A recent study in Spanish postmeno-
pausal women pointed out that patients with T allele and
TT genotype of CD40 rs1883832 C > T have decreasedTable 4 The relationship between CD40 rs4810485 G > T and
rs1883832 C > T polymorphisms and the disease severity of KOA
SNP Severe Moderate Mild χ2 P
(n = 40) (n = 44) (n = 49)
rs4810485 G > T
GG 26 (63.41) 10 (23.26) 8 (16.33)
GT 11 (27.5) 24 (54.5) 28 (57.1) 25.38 < 0.001
TT 4 (10.00) 9 (20.5) 13 (26.53)
G allele 63 (78.75) 44 (50.00) 44 (44.90)
T allele 19 (23.75) 42 (47.73) 54 (55.10) 20.17 < 0.001
rs1883832 C > T
CC 3 (7.32) 7 (16.28) 11 (22.4)
CT 20 (48.78) 25 (58.14) 30 (61.22) 10.11 0.039
TT 18 (43.90) 11 (25.58) 8 (16.33)
C allele 26 (32.50) 39 (44.32) 52 (53.06)
T allele 56 (70.00) 47 (53.41) 46 (46.94) 8.358 0.015
Note: CD40 Cluster of Differentiation 40, KOA Knee osteoarthritis, SNP Single
nucleotide polymorphismCD40 expression and lowered bone mineral density
(BMD) at femoral neck and spine sites, leading to the re-
duced expression of osteoprotegerin (OPG), thereby in-
creasing the susceptibility to osteopenia or osteoporosis
[33]. Previous evidences showed that KOA patients also
have greater BMD and higher OPG levels in the serum
and synovial fluid than the normal controls [34, 35]. In
addition, shortage of CD40 rs4810485 T in RA and SLE
is due to decreased expression of CD40 in peripheral
blood mononuclear cells and B cells, while sustained ex-
pression of CD40L and elevated expression of CD40 in
RA and SLE patients are the main causes of enhanced
activation of humoral and cellular immunity, activation
of non-cellular immune target, and eventually disease
[36]. It has been found that in ACS and breast cancer
patients, the frequency of CC genotype in CD40-1 T > C
increased significantly compared to healthy controls, and
CD40-1 T > C significantly increased the risk of these
two diseases [37].
However it should be disclosed that the mechanism of
correlation is not fully understood at present. Although
133 KOA patients and 143 healthy controls were en-
rolled in this study, the sample size was still not big
enough, and multiple risk factors were revealed for KOA
in previous researches that we failed to take into consid-
erations due to limited sample and funding, such as
meniscectomy and regular sports participation [38, 39].
Besides, the association between a high CD40 expression
and patients with TT genotype of rs1883832 C > T re-
quires further investigation. In addition, replication and
Table 5 Binary logistic regression analysis for the disease severity of KOA
Variables B S.E. Wald Df P Exp (B) 95% CI
rs4810485 TT −1.528 0.612 6.238 1 0.013 0.217 0.065 ~ 0.720
rs1883832 TT 1.333 0.671 3.942 1 0.047 3.793 1.017 ~ 14.140
Age 0.601 0.46 1.703 1 0.192 1.824 0.740 ~ 4.496
Gender 0.439 0.494 0.789 1 0.374 1.551 0.589 ~ 4.085
BMI 0.421 0.595 0.499 1 0.480 1.523 0.474 ~ 4.892
Smoking status 0.295 0.278 1.125 1 0.289 1.343 0.779 ~ 2.317
Alcohol consumption −0.061 0.491 0.015 1 0.901 0.941 0.359 ~ 2.465
Heavy labor −0.006 0.526 0 1 0.991 0.994 0.355 ~ 2.788
Living environment −3.491 1.13 9.538 1 0.002 0.030 0.003 ~ 0.279
Note: KOA Knee osteoarthritis, BMI Body mass index, B Beta, S.E. Standard error, CI Credibility interval
Deng et al. BMC Musculoskeletal Disorders  (2017) 18:115 Page 7 of 8fine mapping of SNP in KOA patients are expected for
further research.
Conclusions
In summary, our results demonstrated that BMI and
living environment are external factors for the susceptibil-
ity to KOA. TT genotype and T allele of rs4810485 G > T
are protective factors for KOA, while C allele and geno-
type CC of rs1883832 C > T can increase the susceptibility
of KOA. The results of this study opened a new avenue
for investigation that may lend insight into KOA.
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Additional file 1: Figure S1. Block diagram of CD40 rs4810485 G > T
and rs1883832 C > T. Note: CD40, Cluster of Differentiation 40. (EPS
928 kb)
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